Table 3.
Patients using IFN-β ±GA | MS (n=19) | Control (n=25) | P value |
---|---|---|---|
RI | 0.49 (0.39–0.80) | 0.46 (0.34–0.60) | 0.195 |
PI | 0.79 (0.65–1.28) | 0.74 (0.56–1.14) | 0.098 |
S/D | 1.94 (1.68–3.20) | 1.89 (1.51–2.68) | 0.222 |
PSV (cm/s) | 10.88 (4.20–16.40) | 7.78 (5.05–20.20) | 0.601 |
Patients using only IFN-β | MS (n=15) | Control (n=25) | P value |
RI | 0.51 (0.41–0.80) | 0.46 (0.34–0.60) | 0.070 |
PI | 0.85 (0.69–1.28) | 0.74 (0.56–1.14) | 0.038 |
S/D | 1.94 (1.68–3.20) | 1.89 (1.51–2.68) | 0.111 |
PSV (cm/s) | 11.23 (4.20–16.40) | 7.78 (5.05–20.20) | 0.515 |
Note: Data are median (range)
RI: Resistance index. PI: Pulsatility index. S/D: Systolic/diastolic ratio. PSV: Peak systolic velocity
Statistics were conducted by Mann Whitney-U test